Your browser doesn't support javascript.
loading
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study.
Choong, Grace M; Liddell, Savannah; Ferre, Roberto A Leon; O'Sullivan, Ciara C; Ruddy, Kathryn J; Haddad, Tufia C; Hobday, Timothy J; Peethambaram, Prema P; Liu, Minetta C; Goetz, Matthew P; Giridhar, Karthik V.
Affiliation
  • Choong GM; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Liddell S; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Ferre RAL; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • O'Sullivan CC; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Haddad TC; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Hobday TJ; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Peethambaram PP; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Liu MC; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Goetz MP; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Giridhar KV; Department of Oncology, Mayo Clinic, Rochester, MN, USA. giridhar.karthik@mayo.edu.
Breast Cancer Res Treat ; 196(1): 229-237, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36045271

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2022 Type: Article Affiliation country: United States